RCM Technologies Inc.

04/03/2026 | Press release | Distributed by Public on 04/03/2026 12:40

RCM TECHNOLOGIES, INC. ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2025 RESULTS (Form 8-K)

RCM TECHNOLOGIES, INC. ANNOUNCES

FOURTH QUARTER AND FISCAL YEAR 2025 RESULTS

Pennsauken, NJ - April 3, 2026 -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty healthcare, and information technology services, today announced financial results for the fourteen and fifty-three weeks ended January 3, 2026.

RCM Technologies reported revenue of $86.5 million for the fourteen weeks ended January 3, 2026 (the current quarter), an increase of 12.4% compared to $76.9 million for the thirteen weeks ended December 28, 2024 (the comparable prior quarter). Gross profit was $24.3 million for the current quarter, a 12.6% increase compared to $21.6 million for the comparable prior quarter. The Company reported GAAP net income of $6.1 million, or $0.80 per diluted share, for the current quarter, compared with $2.9 million, or $0.37 per diluted share, for the comparable prior quarter. The Company reported adjusted EBITDA (non-GAAP) of $9.3 million for the current quarter, as compared to $6.3 million for the comparable prior quarter, an increase of 49.0%. The Company experienced $0.77 of adjusted net income per diluted share (non-GAAP) for the current quarter as compared to $0.49 for the comparable prior quarter.

RCM Technologies reported revenue of $319.4 million for the fifty-three weeks ended January 3, 2026 (the current year), an increase of 14.7% compared to $278.4 million for the fifty-two weeks ended December 28, 2024 (the comparable prior year). Gross profit was $87.9 million for the current year, a 10.2% increase compared to $79.8 million for the comparable prior year. The Company reported GAAP net income of $16.3 million, or $2.14 per diluted share, for the current year compared to $13.3 million, or $1.68 per diluted share, for the comparable prior year. The Company reported adjusted EBITDA (non-GAAP) of $30.7 million for the current year as compared to $25.9 million for the comparable prior year, an increase of 18.9%. The Company reported $2.50 of adjusted net income per diluted share (non-GAAP) for the current year as compared to $2.03 for the comparable prior year.

The Company will not be holding a conference call to discuss these results. Additional information can be found in the Company's Form 10-K.

About RCM

RCM Technologies (NasdaqGM: RCMT) is a business and technology solutions provider with world-class talent in key market segments. We help design, build, and enable the Industries of Tomorrow, Today. Operating at the intersection of resources, critical infrastructure and modernization of industries, RCM is a provider of services in HealthCare, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions. www.rcmt.com.

The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company's actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "believe," "plan," "seek," "could," "can," "should," "are confident" or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company's services, expectations regarding our future revenues and other financial results, such as cash flows, our pipeline, and potential project wins, and our expectations for investment and growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company's actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

Tables to Follow

RCM Technologies, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(In thousands, except share and per share amounts)

Fourteen and Thirteen Weeks Ended

January 3,

2026

December 28,

2024

Revenue

$ 86,476 $ 76,912

Cost of services

62,198 55,343

Gross profit

24,278 21,569

Selling, general and administrative

15,753 16,025

Depreciation and amortization of property and equipment

554 407

Impairment of intangible assets

- 547

Potential stock issuance and financing transactions

- 64

Remeasurement of contingent consideration

- (1,759 )

Operating income

7,971 6,285

Other expense, net

780 516

Income before income taxes

7,191 5,769

Income tax expense

1,087 2,902

Net income

$ 6,104 $ 2,867

Diluted net earnings per share data

$ 0.80 $ 0.37

Diluted weighted average shares outstanding

7,587,448 7,733,142

Fifty-Three and Fifty-Two Weeks Ended

January 3,

2026

December 28,

2024

Revenue

$ 319,404 $ 278,380

Cost of services

231,461 198,602

Gross profit

87,943 79,778

Selling, general and administrative

60,932 56,787

Depreciation and amortization of property and equipment

1,918 1,419

Amortization of acquired intangible assets

- 136

Impairment of intangible assets

- 547

Potential stock issuance and financing transactions

- 323

Remeasurement of contingent consideration

- (1,759 )

Operating income

25,093 22,325

Other expense, net

3,021 2,135

Income before income taxes

22,072 20,190

Income tax expense

5,738 6,863

Net income

$ 16,334 $ 13,327

Diluted net earnings per share data

$ 2.14 $ 1.68

Diluted weighted average shares outstanding

7,635,740 7,939,381

RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis

(Unaudited)

(In thousands)

The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures ("Adjusted operating income," "EBITDA," "Adjusted EBITDA," "Adjusted net income" and "Adjusted diluted net earnings per share") are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors' overall understanding of our current financial performance and period-to-period comparisons. Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income, and Adjusted diluted net earnings per share should not be considered alternatives to operating income or net income, as the case may be, as an indicator of performance. In addition, Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income, and Adjusted diluted net earnings per share do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The following unaudited table presents the Company's GAAP operating income and GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income, and Adjusted diluted net earnings per share for the fourteen and fifty-three weeks ended January 3, 2026, and the thirteen and fifty-two weeks ended December 28, 2024.

Fourteen and Thirteen Weeks

Ended

Fifty-Three and Fifty-Two Weeks

Ended

January 3,

2026

December 28,

2024

January 3,

2026

December 28,

2024

GAAP operating income

$ 7,971 $ 6,285 $ 25,093 $ 22,325

Adjustments

Remeasurement of contingent consideration

- (1,759 ) - (1,759 )

Equity compensation

793 710 3,732 2,864

Potential stock issuance and financing transaction

- 64 - 323

Impairment of intangible assets

- 547 - 547

Adjusted operating income (non-GAAP)

$ 8,764 $ 5,847 $ 28,825 $ 24,300

GAAP net income

$ 6,104 $ 2,867 $ 16,334 $ 13,327

Income tax expense

1,087 2,902 5,738 6,863

Interest expense, net

784 664 2,669 2,215

Depreciation of property and equipment

554 407 1,918 1,419

Amortization of acquired intangible assets

- - - 136

EBITDA (non-GAAP)

$ 8,529 $ 6,840 $ 26,659 $ 23,960

Adjustments

Remeasurement of contingent consideration

- (1,759 ) - (1,759 )

(Gain) loss on foreign currency transactions

(4 ) (148 ) 352 (80 )

Equity compensation

793 710 3,732 2,864

Potential stock issuance and financing transaction

- 64 - 323

Impairment of intangible assets

- 547 - 547

Adjusted EBITDA (non-GAAP)

$ 9,318 $ 6,254 $ 30,743 $ 25,855

RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis (Continued)

(Unaudited)

(In thousands, except per share amounts)

Fourteen and Thirteen Weeks

Ended

Fifty-Three and Fifty-Two Weeks

Ended

January 3,

2026

December 28,

2024

January 3,

2026

December 28,

2024

GAAP net income

$ 6,104 $ 2,867 $ 16,334 $ 13,327

Adjustments

Remeasurement of contingent consideration

- (1,759 ) - (1,759 )

(Gain) loss on foreign currency transactions

(4 ) (148 ) 352 (80 )

Equity compensation

793 710 3,732 2,864

Potential stock issuance and financing transaction

- 64 - 323

Impairment of intangible assets

- 547 - 547

Tax impact from normalized rate

(1,068 ) 1,503 (1,324 ) 900

Adjusted net income (non-GAAP)

$ 5,825 $ 3,784 $ 19,094 $ 16,122

GAAP diluted net earnings per share

$ 0.80 $ 0.37 $ 2.14 $ 1.68

Adjustments

Remeasurement of contingent consideration

- $ (0.22 ) - $ (0.22 )

(Gain) loss on foreign currency transactions

$ (0.00 ) $ (0.02 ) $ 0.04 $ (0.01 )

Equity compensation

$ 0.11 $ 0.09 $ 0.49 $ 0.36

Potential stock issuance and financing transaction

- $ 0.01 - $ 0.04

Impairment of intangible assets

- $ 0.07 - $ 0.07

Tax impact from normalized rate(a)

$ (0.14 ) $ 0.19 $ (0.17 ) $ (0.11 )

Adjusted diluted net earnings per share (non-GAAP)

$ 0.77 $ 0.49 $ 2.50 $ 2.03

(a)

Amount reflects an adjustment to income tax expense applied to non-GAAP adjusted consolidated taxable income. The Company used an estimated effective income tax rate of 27.0% for both periods presented, approximating the Company's federal USA income tax rate plus the tax-affected rate for states and Puerto Rico.

RCM Technologies, Inc.

Summary of Selected Income Statement Data

(Unaudited)

(In thousands)

Fourteen Weeks Ended January 3, 2026

Specialty

Health Care

Engineering

Life Sciences,

Data and Solutions

Consolidated

Revenue

$ 47,999 $ 30,404 $ 8,073 $ 86,476

Cost of services

34,067 22,608 5,523 62,198

Gross profit

$ 13,932 $ 7,796 $ 2,550 $ 24,278

Gross profit margin

29.0 % 25.6 % 31.6 % 28.1 %

Thirteen Weeks Ended December 28, 2024

Specialty

Health Care

Engineering

Life Sciences,

Data and Solutions

Consolidated

Revenue

$ 41,011 $ 26,279 $ 9,622 $ 76,912

Cost of services

28,474 21,098 5,771 55,343

Gross profit

$ 12,537 $ 5,181 $ 3,851 $ 21,569

Gross profit margin

30.6 % 19.7 % 40.0 % 28.0 %

Fifty-Three Weeks Ended January 3 2026

Specialty

Health Care

Engineering

Life Sciences,

Data and Solutions

Consolidated

Revenue

$ 164,104 $ 120,486 $ 34,814 $ 319,404

Cost of services

116,702 93,104 21,655 231,461

Gross profit

$ 47,402 $ 27,382 $ 13,159 $ 87,943

Gross profit margin

28.9 % 22.7 % 37.8 % 27.5 %

Fifty-Two Weeks Ended December 28, 2024

Specialty

Health Care

Engineering

Life Sciences,

Data and Solutions

Consolidated

Revenue

$ 142,679 $ 96,459 $ 39,242 $ 278,380

Cost of services

100,146 73,916 24,540 198,602

Gross profit

$ 42,533 $ 22,543 $ 14,702 $ 79,778

Gross profit margin

29.8 % 23.4 % 37.5 % 28.7 %

RCM Technologies, Inc.

Consolidated Balance Sheets

(Unaudited)

(In thousands, except share amounts)

January 3,

December 28,

2026

2024

Current assets:

Cash and cash equivalents

$ 2,922 $ 4,729

Accounts receivable, net of provision for credit losses of $1,229 and $1,570 at January 3, 2026 and December 28, 2024, respectively

81,243 77,960

Transit accounts receivable

8,017 7,315

Prepaid expenses and other current assets

7,704 7,034

Total current assets

99,886 97,038

Property and equipment, net

7,265 7,368

Other assets:

Deposits

261 230

Deferred tax assets, foreign

6 120

Goodwill

22,147 22,147

Operating right of use asset

4,832 5,174

Total other assets

27,246 27,671

Total assets

$ 134,397 $ 132,077

Current liabilities:

Accounts payable and accrued expenses

$ 9,649 $ 13,369

Transit accounts payable

16,247 23,870

Accrued payroll and related costs

10,784 9,929

Finance lease payable

843 698

Income taxes payable

391 346

Operating right of use liability

1,209 1,046

Contingent consideration from acquisitions

- 212

Deferred revenue

14,761 4,163

Total current liabilities

53,884 53,633

Deferred income taxes, net, domestic

5,673 4,526

Finance lease payable, net of current position

380 1,112

Operating right of use liability, net of current position

3,813 4,355

Borrowings under line of credit

24,673 34,967

Total liabilities

88,423 98,593

Contingencies (note 16) and Commitments (note 18)

Stockholders' equity:

Preferred stock, $1.00 par value; 5,000,000 shares authorized; no shares issued or outstanding

- -

Common stock, $0.05 par value; 40,000,000 shares authorized; 18,004,241 shares issued and 7,351,400 shares outstanding at January 3, 2026 and 17,838,372 shares issued and 7,602,113 shares outstanding at December 28, 2024

900 890

Additional paid-in capital

122,244 118,845

Accumulated other comprehensive loss

(2,814 ) (2,920 )

Accumulated deficit

10,396 (5,938 )

Treasury stock, 10,652,841 shares at January 3, 2026 and 10,236,259 shares at December 28, 2024

(84,752 ) (77,393 )

Stockholders' equity

45,974 33,484

Total liabilities and stockholders' equity

$ 134,397 $ 132,077

RCM Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

Fourteen and Thirteen Weeks

Ended

January 3,

2026

December 28,

2024

Net income

$ 6,104 $ 2,867

Adjustments to reconcile net income to cash used in operating activities

3,911 2,693

Changes in operating assets and liabilities:

Accounts receivable

1,097 (2,064 )

Prepaid expenses and other current assets

(3,541 ) (1,917 )

Net of transit accounts receivable and payable

1,005 (5,345 )

Accounts payable and accrued expenses

(3,415 ) 1,861

Accrued payroll and related costs

(2,012 ) (1,698 )

Operating lease liabilities

(396 ) (280 )

Income taxes payable

144 140

Deferred revenue

8,530 2,121

Deposits

18 (15 )

Total adjustments

5,341 (4,504 )

Net cash provided by (used in) operating activities

$ 11,445 $ (1,637 )

Net cash used in investing activities

(197 ) (983 )

Net cash (used in) provided by financing activities

(9,567 ) 4,307

Effect of exchange rate changes on cash and cash equivalents

(68 ) (114 )

Increase in cash and cash equivalents

$ 1,613 $ 1,573

Fifty-Three and Fifty-Two Weeks

Ended

January 3,

2026

December 28,

2024

Net income

$ 16,334 $ 13,327

Adjustments to reconcile net income to cash used in operating activities

8,991 6,893

Changes in operating assets and liabilities:

Accounts receivable

(4,152 ) (7,271 )

Prepaid expenses and other current assets

(676 ) (2,392 )

Net of transit accounts receivable and payable

(8,325 ) (5,656 )

Accounts payable and accrued expenses

(3,484 ) 1,101

Accrued payroll and related costs

848 (1,265 )

Operating lease liabilities

(1,205 ) (966 )

Income taxes payable

36 34

Deferred revenue

10,628 2,282

Deposits

(30 ) 83

Total adjustments

2,631 (7,157 )

Net cash provided by operating activities

18,965 6,170

Net cash used in investing activities

(1,595 ) (2,572 )

Net cash used in financing activities

(19,038 ) (4,828 )

Effect of exchange rate changes on cash and cash equivalents

(139 ) (325 )

Decrease in cash and cash equivalents

$ (1,807 ) $ (1,555 )
RCM Technologies Inc. published this content on April 03, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 03, 2026 at 18:40 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]